New equities of information in an electronic age.

Autor Zielinski, C.
Vydáno 1995

Professor Gouri Shankar Bhattacharyya

Autor Zielinski, C.
Vydáno v ESMO Open (2021)

Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer

Autor Zielinski, C., Knapp, S., Mascaux, C., Hirsch, F.
Vydáno 2013

Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment

Autor Zielinski, C., Pehamberger, H., Endler, A. T., Knapp, W.
Vydáno 1979

Primary pulmonary lymphoma in a patient with the acquired immune deficiency syndrome.

Autor Poelzleitner, D, Huebsch, P, Mayerhofer, S, Chott, A, Zielinski, C
Vydáno 1989

Recurrent pyoderma in a family with a defect in leucocyte locomotion

Autor Zielinski, C C, Dremsek, P A, Eibl, Martha M
Vydáno 1985

Modulation of leucocyte locomotion by interleukin-1.

Autor Zielinski, C C, Pesau, B, Kalinowski, W, Müller, C
Vydáno 1990

Functional activity of peripheral mononuclear cells in cystic fibrosis: antibodies and plaque formation.

Autor Götz, M, Zielinski, C C, Ahmad, R, Eibl, M
Vydáno 1982

Two types of human Th17 cells with pro- and anti-inflammatory properties and distinct roles in autoinflammation

Autor Noster, R, de Koning, H, Sallusto, F, Zielinski, C
Vydáno v Pediatr Rheumatol Online J (2015)

Con A-induced suppressor cells in children with acute lymphoblastic leukaemia.

Autor Eibl, M, Krepler, P, Schmidmeier, W, Zielinski, C, Winterleitner, H
Vydáno 1980

Divergent patterns of leucocyte locomotion in experimental post-traumatic osteomyelitis.

Autor Müller, C., Zielinski, C. C., Passl, R., Eibl, M. M.
Vydáno 1984

Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.

Autor Zielinski, C. C., Müller, C., Tichatschek, E., Aiginger, P.
Vydáno 1989

Recurrent pyoderma in a family with a defect in leucocyte locomotion.

Autor Zielinski, C C, Dremsek, P A, Ahmad, R, Eibl, M M
Vydáno 1984

Plaque-forming cells in human cord blood: studies on T and B cell function.

Autor Eibl, M, Zielinski, C C, Ahmad, R, Steurer, F, Rockenschaub, A
Vydáno 1980

Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients

Autor Reitter, E-M, Ay, C, Kaider, A, Pirker, R, Zielinski, C, Zlabinger, G, Pabinger, I
Vydáno 2014

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.

Autor Zielinski, C. C., Schnack, B., Grbovic, M., Brodowicz, T., Wiltschke, C., Steger, G., Pflüger, H., Marberger, M.
Vydáno 1998

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable

Autor Vogl, U M, Zehetgruber, H, Dominkus, M, Hejna, M, Zielinski, C C, Haitel, A, Schmidinger, M
Vydáno 2006

Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-α and retinoids

Autor Brodowicz, T, Wiltschke, C, Kandioler-Eckersberger, D, Grunt, T W, Rudas, M, Schneider, S M, Hejna, M, Budinsky, A, Zielinski, C C
Vydáno 1999

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status

Autor Brodowicz, T, Kandioler, D, Tomek, S, Ludwig, C, Rudas, M, Kunstfeld, R, Koestler, W, Hejna, M, Budinsky, A, Wiltschke, C, Zielinski, C C
Vydáno 2001

P04.03 Analysis of the inflammatory tumor microenvironment in meningeal malignancies

Autor Berghoff, A. S., Kresl, P., Rajky, O., Widhalm, G., Ricken, G., Hainfellner, J., Marosi, C., Zielinski, C. C., Birner, P., Preusser, M.
Vydáno v Neuro Oncol (2016)